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Connexin 43 expression (Cx43) is increased in cardiac fibroblasts (CFs) following myocardial infarction. Here,
potential mediators responsible for increasing Cx43 expression and effects of differential CF phenotype on cardiac
myocyte (CM) function were investigated. Stimulating adult rat CFs with proinflammatory mediators revealed that
interleukin 1β (IL-1β) significantly enhanced Cx43 levels through the IL-1β pathway. Additionally, IL-1β reduced
mRNA levels of themyofibroblast (MF)markers: (i) connective tissue growth factor (CTGF) and (ii) α smoothmuscle
actin (αSMA), compared to control CFs. A co-culture adult rat CM:CF model was utilised to examine cell-to-cell
interactions. Transfer of calcein from CMs to underlying CFs suggested functional gap junction formation. Func-
tional analysis revealed contraction duration (CD) of CMs was shortened in co-culture with CFs, while treatment of
CFs with IL-1β reduced thismechanical effect of co-culture. No effect on action potential rise time or duration of CMs
cultured with control or IL-1β-treated CFs was observed. These data demonstrate that stimulating CFs with IL-1β
increases Cx43 and reduces MF marker expression, suggesting altered cell phenotype. These changes may underlie
the reduced mechanical effects of IL-1β treated CFs on CD of co-cultured CMs and therefore have an implication for
our understanding of heterocellular interactions in cardiac disease.1. Introduction
Cardiac myocytes (CMs) are responsible for cardiac contraction and
therefore are undoubtedly the most important cell type in the heart.
However, cardiac fibroblasts (CFs) contribute to a large proportion of the
cellular composition and have a major role in the heart by facilitating the
turnover of the extracellular matrix (ECM). Following cardiac insult, CFs
proliferate in mass and undergo a phenotypic switch to become myofi-
broblasts (MFs) [1]. These cells have a contractile phenotype, developing
the expression of α-smooth muscle actin (αSMA), and secrete excessive
volumes of ECM components, resulting in typical fibrosis seen after
injury [2]. This contributes to cardiac dysfunction and dramatically in-
creases the proarrhythmic potential of the heart, by creating structures
that disrupt the conduction through the heart and predispose the con-
duction pathway to re-entry [3].
In the healthy heart, gap junctions (GJs), composed of connexin (Cx)
proteins, are mainly present at the intercalated discs between neigh-
bouring CMs and assist in rapid electrical conduction through the
myocardium. Reduced and/or disorganised Cx43 (the main cardiac
connexin) expression in CMs has been demonstrated in many.A. Nicklin).
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evier Ltd. This is an open accesscardiomyopathies [4, 5]. In contrast, CFs isolated from experimental
models of myocardial infarction (MI) hearts, have been demonstrated to
have augmented Cx43 levels in comparison to CFs from healthy hearts
[6]. Interestingly this enhanced expression was also apparent in CFs from
the area of infarct versus remote, noninfarcted regions [7]. The transfer
of calcein dye between CMs and CFs in vitro [8, 9, 10] and in situ [11]
suggests the presence of GJs between cell types. Additionally, electrical
signals have been shown to propagate from one band of CMs to another
when they were separated by CFs over distances of up to 300 μm in a
culture model [12], demonstrating the ability of CFs to passively conduct
electrical impulses.
Co-culture studies, mainly using cells from a neonatal origin, have
suggested CFs can enhance the risk for arrhythmias involving both
paracrine mediators and direct cell-to-cell interactions [13, 14, 15]. For
instance, studies have reported a rise in the maximal diastolic potential
(MDP; the most negative point of the action potential (AP))/resting
membrane potential (RMP) of CMs [15, 16] as well as a reduction in
conduction velocity (CV) [13, 15, 16] and enhanced spontaneous depo-
larisations [17] in co-cultures in comparison to CMs alone. Greater
expression of Cx43 in CFs, seen in CFs from MI hearts, could result in10 December 2019
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effects of CFs on CMs. Indeed, lentiviral (LV) vector-mediated silencing of
Cx43 in CFs, diminished the rise in CMMDP and slowing of CV caused by
CFs [13].
Interestingly, conditioned media from CFs from MI hearts induced a
significant reduction in the CV and AP duration (APD) of rat neonatal
cultures, whereas conditioned media from CFs isolated from healthy
hearts had no effect [6]. Additionally, transforming growth factor (TGF)
β1, a key driver of CF to MF transition [18], was shown to enhance the
proarrhythmic nature of CFs on CMs in a neonatal cell culture model, by
causing depolarisation of the RMP of CMs and promoting increased
ectopic activity [19]. These effects in neonatal preparations were
attributed to direct heterocellular coupling [19]. Furthermore, the ability
of CFs to trigger spontaneous AP generation in CMs was shown to be
dependent on αSMA expression in CFs [20]. Together these studies
suggest the MF phenotype is able to cause detrimental effects on CMs in
comparison to normal CFs.
Here, potential factors which may be responsible for the enhanced
Cx43 expression in CFs found followingMI were investigated. Interleukin
(IL)-1β was found to enhance Cx43 levels, therefore the IL-1β pathway
was dissected to establish the mechanism for this upregulation.
Furthermore, untreated and IL-1β treated CFs were investigated for their
effects on CM contraction and electrical activity in an adult CM: CF co-
culture model.
2. Materials and methods
Expanded methods are available online, including full immunofluo-
rescence and immunoblotting protocols.
2.1. Isolation and culture of rat adult ventricular cardiac fibroblasts and
myocytes
Adult maleWistar rats (200–300g, Envigo, UK) were housed under 12
h light/dark cycles at ambient temperature with ad lib provision of
standard chow and drinking water. Animals were killed by Schedule 1
according to the UK Animals (Scientific Procedures) Act 1986 and ex-
periments approved by the University of Glasgow's Animal Welfare and
Ethnical Review Board (AWERB). Hearts were removed from the thorax
and lungs and placed in ice-cold solution. ADS buffer (composed of 116.4
mM NaCl, 20.0 mM HEPES, 1.0 mM NaH2PO4, 5.6 mM Glucose, 5.4 mM
KCl, 0.8 mM MgSO4: pH 7.4) was used for CF isolation and heparinised
Krebs-Henseleit (KH) solution (composed of 120.0 mM NaCl, 20.0 mM
HEPES, 5.4 mM KCl, 0.5 mM NaH2PO4, 3.5 mM MgCl2.6H20, 20.0 mM
Taurine, 10.0 mM Creatine and 11.0 mM Glucose (Anhydrous): pH 7.4)
used for CM isolation.
CF cultures were obtained by an enzymatic digestion method of the
ventricular muscle, modified from previous published protocols [21, 22].
At the end of the digestion, cells were then pelleted and cultured in
Dulbecco's Modified EagleMedium: Nutrient Mixture F-12 (DMEM/F-12)
supplemented with 10 % (v/v) foetal bovine serum (FBS), 100 I.U/mL
penicillin and 100 μg/mL streptomycin. Culture media was replaced after
2–3 h. Adult rat CMs were isolated using a Langendorff perfusion set up
similar to methods described elsewhere [23]. Expanded CF and CM
isolation procedures are described in the supplementary material.
Where reduced serum media was required, DMEM/F-12 containing
0.5 % FBS, 100 I.U/mL penicillin and 100 μg/mL streptomycin was used.
All plastics for CF culture were coated with poly-L-lysine.
2.2. Cardiac fibroblast stimulation
CFs were quiesced in reduced serumDMEM/F-12 (0.5 % FBS) for 24 h
prior to stimulation and subsequent stimulations performed in this
media. Cells were then reintroduced into culture DMEM/F-12 (10% FBS)
or treated with 500 nM angiotensin (Ang) II (Phoenix Pharmaceuticals,
Germany), 10 ng/mL recombinant human TGFβ1 (R & D systems, USA),210 ng/mL recombinant human tumor necrosis factor (TNF)α (Peprotech,
UK), 10 ng/mL recombinant human IL-1β (R & D systems), 10 ng/mL
recombinant rat IL-1α (Peprotech) and 50 ng/mL recombinant human IL-
6 (with or without 50 ng/mL recombinant human soluble IL-6 receptor α
[sIL-6Rα]; both purchased from Peprotech). Cx43 mRNA (ThermoFisher
Scientific, assay ID: Rn01433957_m1) was then measured 24 h following
stimulation.
A range of IL-1β pathway inhibitors were utilised to dissect the IL-1β
pathway. Firstly, 10 ng/mL IL-1β and recombinant human IL-1 receptor
antagonist (IL-1Ra [Peprotech]) at 0.25, 0.5 or 1 μg/mL were added
simultaneously to the cells. In a subset of experiments, a NF-κB inhibitor,
SC-514 (100 μM [Cayman Chemical, USA]) was added 30 min prior to
the addition of 10 ng/mL IL-1β. Furthermore, cells were incubated with
inhibitors of p38 MAPK (SB203580 [InvivoGen, UK]; 10 μM), JNK
(SP600125 [InvivoGen]; 20 μM) and MEK1 (AZD6244 [Selleckchem,
USA]; 10 μM) for 1 h before IL-1β stimulation. As a vehicle control, 0.1%
DMSO was used and all stimulations were performed for 24 h. Cx43
mRNA and protein expression were examined by qRT-PCR and western
blotting respectively.
TGFβ1 is a well-established mediator of fibroblast to MF trans-
differentiation [18, 24, 25]. Conversely, IL-1β has been reported to
inhibit TGFβ1-mediated MF transdifferentiation in cardiac, dermal and
lung fibroblasts [18, 26, 27]. Therefore, to identify the phenotype of
IL-1β treated CFs, cells were stimulated with 10 ng/mL IL-1β, 10 ng/mL
TGFβ1 or with a combination of both for 24 h and the mRNA expression
of the MF markers, CTGF (assay ID: Rn01537279_g1) and αSMA (assay
ID: Rn01759928_g1), examined.
2.3. Co-culture model
CFs were seeded at 5 104 cells/35mm glass bottomed petri dish and
cultured for 48 h to allow the cells to reach a confluent monolayer. Cells
were then serum starved for 24 h prior to the addition of 1  104 CM
rods. In experiments that involved the stimulation of CFs with 10 ng/mL
IL-1β, CFs were serum starved for 24 h before stimulation. Cells were
then washed once with sterile PBS prior to the addition of 1  104 CM
rods. CMs were seeded at the same density on laminin coated plates. CMs
for calcein dye transfer and CM contraction experiments were added to
CF monolayers in phenol red, reduced serum DMEM/F-12 whereas cells
for CM AP measurements were maintained in phenol red-free, reduced
serum DMEM/F-12. Co-cultures were fixed on completion of experiments
for vimentin immunofluorescence.
2.4. Calcein dye transfer studies
The presence of functional GJs between CFs and CMs was assessed by
imaging the transfer of calcein from preloaded CMs to an underlying
monolayer of CFs. Freshly isolated CMs were loaded with 5 μM calcein
acetoxymethyl ester (AM) made up in reduced serum DMEM/F-12 and
incubated for 30 min at 37 C. CMs were then washed three times in PBS
before the addition of 1  104 CM rods to each dish. Images were taken
on the on the LSM 510Meta laser scanning confocal microscope using the
Argon/2 (488) laser, immediately and 20 h following CM addition, both
focusing on the CM and CF layer to detect the calcein location. The laser
intensity was increased at the 20 h time point due to the calcein fluo-
rescence fading over time and to detect the transfer of calcein to the
underlying CF layer.
2.5. Contraction measurement
CM contraction measurements were recorded following 24 h of cul-
ture while cells were maintained at 5 % CO2, 37 C and in reduced serum
DMEM/F-12 for the duration of the recordings. Cells were field stimu-
lated at 1 Hz and the threshold voltage of each cell determined by
increasing the voltage by 1 V increments until the cell started to respond.
CMs were paced at 30 % above their threshold for 1 min before images
Figure 1. Immunolocalisation of αSMA, vimentin and Cx43 in passage two CFs.
Immunostaining of αSMA (red: mouse monoclonal anti-αSMA [clone IA4]),
vimentin (red: mouse monoclonal anti-vimentin [clone LN-6]) and Cx43 (green:
rabbit polyclonal anti-Cx43) was performed on cells grown on glass for 48 h (n¼
3). All images were normalised to the individual IgG shown down the right hand
side. Nuclei were counterstained with DAPI (blue). Areas surrounded by a red
box are magnified within the image and the white arrow denotes punctate
expression of Cx43 at the cell membrane. Images were taken at x25 magnifi-
cation. Scale bar represents 100 μm.
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software. Typically, the contraction of 13 cells per condition in one
experiment was recorded. The individual images were then stacked to
construct a video of CM contraction and analysed on Image J using a
macro (kind gift from Dr. Francis Burton [University of Glasgow]) to
determine contraction duration (CD). The duration from the point of 50%
contraction to 50% of the relaxation (CD50) was used as an indication of
CD.
2.6. Action potential measurements
AP recordings were taken from CMs that had been freshly isolated
and from CMs that had been cultured for 24 h. Phenol red can produce
fluorescence [28] potentially generating artefacts in the AP traces so all
recordings were performed in reduced serum DMEM/F-12 absent of
phenol red. FluoVolt™membrane potential kit (ThermoFisher Scientific)
was used to detect changes in the CM membrane potential. AP mea-
surements were performed at 37 C within a darkened room. Cells were
field stimulated at 1 Hz and using 40 V pulses and allowed to acclimatise
for 5 min prior to the first recording. Next, 470 nm light used to excite the
FluoVolt™ within the CMs and changes in membrane potential detected
by CellOPTIQ software (Clyde Biosciences, UK) over a 10 s period. APs
were analysed using the CellOPTIQ software, where APs were averaged
and the average TRise (time taken from 10-90 % depolarisation) and
APD80 values recorded for each cell.
2.7. Statistical analysis
All experiments were performed at least three times. Data from qRT-
PCR experiments is represented as RQ  rqmax, where rqmax is indicative
of the standard error of the mean (SEM) and is calculated from the ΔCT
value from each experiment. All other data is represented as mean 
SEM. For single CM data, statistical analysis was performed on the mean
values for each heart. A Student's unpaired, two-tailed t-test was per-
formed where there were two conditions. A repeated measures one-way
analysis of variance (ANOVA) with a Dunnett's or Tukey's multiple
comparisons test was performed where there were three or more con-
ditions. All statistical analysis was performed using Graphpad Prism 4
software (GraphPad Software Inc., California, USA) and a P value < 0.05
was considered statistically significant.
2.8. Data availability
The datasets generated during and/or analysed during the current
study are available from the corresponding author on reasonable request.
3. Results
Passage 2–4 CFs were utilised throughout this study. By passage 2,
CFs had a high expression of αSMA, suggesting differentiation of CFs to
MFs in culture (Figure 1). CFs also expressed the fibroblast marker,
vimentin, and Cx43 at the cell membrane (Figure 1).
3.1. IL-1β stimulation of CFs promotes enhanced Cx43 mRNA and protein
levels
Previous studies have shown that CFs from infarcted hearts have
enhanced Cx43 expression [6, 7]. As proinflammatory/profibrotic me-
diators are also augmented in cardiac disease [29, 30, 31], the effect of a
range of proteins, including Ang II, TGFβ1, IL-1β, IL-1α, TNFα, IL-6 and
IL-6 in combination with the sIL-6R on Cx43 mRNA expression was
examined in CFs (Figure 2). Cx43 mRNA expression in CFs reintroduced
into culture media (10 % FBS) following serum starvation was shown to
be significantly greater than in control cells (relative quantification (RQ):
3.3  2.1; P < 0.001; Figure 2A). Stimulation of CFs cultured in the
absence of FBS with TGFβ1, IL-1β, IL-1α or IL-6 in combination with the3sIL-6R induced a significant upregulation of Cx43 mRNA expression (RQ:
1.7  1.1 [P < 0.05], 10.2  3.1 [P < 0.001], 10.0  4.9 [P < 0.001]
and 2.0  1.3 [P < 0.01] respectively; Figure 2A). Conversely, there
were no significant changes in Cx43 mRNA following stimulation with
Ang II, TNFα or IL-6 alone (RQ: 0.7  0.4, 1.3  0.8, 1.2  0.8 respec-
tively; Figure 2A).
IL-1β is one of the earliest cytokines to be detected in the plasma of MI
patients [32], therefore its effects on CF function are particularly inter-
esting. As both isoforms of IL-1 induced a similar increase in Cx43mRNA,
and are known to have indistinguishable actions [33], only IL-1β was
investigated further. Cx43 protein expression was found to be signifi-
cantly enhanced, particularly at the cell membrane (Figure 2B), by IL-1β
treatment as detected by immunofluorescence (P < 0.01; Figures 2B and
2C).
Next, the mechanism by which IL-1β upregulated Cx43 expression
was investigated. IL-1β-mediated upregulation of Cx43 mRNA was dose-
dependently inhibited by the IL-1Ra (Figure 3A), indicating signalling
through the IL-1R. Furthermore, as NF-κB is known to be an important
regulator of IL-1β actions on CFs [34], the specific NF-κB inhibitor,
SC-514 [35,36], was utilised. SC-514 significantly inhibited the
IL-1β-mediated increase in Cx43 mRNA levels (Figure 3B). Similar to
immunofluorescence data (Figures 2B and 2C), IL-1β appeared to in-
crease Cx43 protein when detected through western blot (Figure 3C), an
effect blunted in the presence of SC-514 (Figure 3C). Additionally, in-
hibition of MEK1 via the inhibitor AZD6244 was demonstrated to
significantly inhibit Cx43 mRNA upregulation by IL-1β at the mRNA
level, whereas there was no effect following inhibition of p38 MAPKwith
SB203580 or JNK with SP600125 (Figure 3D). Furthermore, the increase
in Cx43 protein (Figure 3E) was blunted in the presence of SB203580
(Figure 3E) and AZD6244 (Figure 3E), whereas there was no inhibitory
effect of the JNK inhibitor SP600125 (Figure 3E).3.2. IL-1β and TGFβ1 have differential effects on the myofibroblast
markers, αSMA and connective tissue growth factor (CTGF)
Many mediators have been reported to induce fibroblast to MF
transition, one of which is TGFβ1 [18,37]. Interestingly, IL-1β has been
Figure 2. Effect of proinflammatory mediators on Cx43 expression in CFs. (A) Quiesced cells were stimulated with 10% FBS, Ang II (500nM), TGFβ1, IL-1β, IL-1α, TNFα
(all 10ng/mL) or IL-6 in the presence or absence of the sIL-6R (both 50 ng/mL) for 24 h. Cells maintained in 0.5% FBS media were used as a control. Data represented as
relative quantification (RQ)  rqmax normalised to UBC (n ¼ 3). *P < 0.05, **P < 0.01, ***P < 0.001 vs. control (one-way repeated measures ANOVA with Dunnett's
multiple comparison test). (B) Immunostaining of Cx43 (green) in CFs maintained in 0.5% FBS media (control) or treated with 10ng/mL IL-1β (n¼3). Nuclei were
counterstained with DAPI (blue). Images were normalised to an IgG control shown in the upper right panel. The areas surrounded by a red box are expanded within the
merged image or in the lower right panel for control and IL-1β stimulated cells respectively.White arrows indicate punctate Cx43 expression (green: rabbit polyclonal anti-
Cx43). Images were taken at x25magnification. Scale bar represents 100 μm. (C) Quantification of immunofluorescence normalised to the total cell number present in the
images. At least 2 images per condition were analysed in each of the 3 independent experiments. **P < 0.01 vs. control (unpaired, two tailed t-test).
L. McArthur et al. Heliyon 6 (2020) e03031shown to inhibit TGFβ1-mediated MF differentiation of cardiac, dermal
and lung fibroblasts [18, 26, 27]. Here we examined the effects of
treatment of CFs with IL-1β and TGFβ1 alone or in combination on the
expression of MF markers. As expected, IL-1β stimulation was found to
have predominantly opposing actions on CTGF and αSMA gene expres-
sion to TGFβ1 (Figure 4). For instance, IL-1β promoted an 8 and 59 fold
reduction in CTGF (RQ: 0.12  0.05, P < 0.001; Figure 4A) and αSMA
(RQ: 0.02 0.02, P < 0.001; Figure 4B) levels, respectively. Conversely,
TGFβ1 induced a significant up-regulation of CTGF (RQ: 2.3  0.3, P <
0.05) but no significant change in αSMA expression (RQ: 2.0  0.1).4αSMA expression in IL-1β and TGFβ1 co-stimulated cells was significantly
reduced in comparison to cells treated with TGFβ1 alone (RQ: 0.3  0.16
vs. 2.0  0.1, IL-1β þ TGFβ1 vs. TGFβ1 alone, P < 0.05).
3.3. Evidence of functional gap junctions between rat adult CFs and CMs
following 20 h of co-culture
The presence of functional GJs between adult CMs and CFs was
assessed by calcein dye transfer in a co-culture model [8, 9, 10]
(Figure 5A). Calcein was confined to CMs immediately following
Figure 3. Effect of IL-1β pathway inhibitors on IL-1β mediated up-regulation of Cx43 mRNA expression in CFs. (A–E) Quiesced cells were stimulated with 10 ng/mL
IL-1β for 24 h and inhibitors added at (A) the same time or (B and C) 30 min (D and E) to 1 h prior to stimulation. Cells maintained in 0.5% FBS were used as a control
and 0.1% DMSO used as a vehicle control where required. (A, B and D) Cx43 mRNA data is represented as relative quantification (RQ) rqmax normalised to UBC. (C
and E) Representative western blot showing Cx43 and β-tubulin control expression in replicate wells. The concentration of inhibitors used were (A) 0.25, 0.5 or 1 μg/
mL human recombinant IL-1β receptor antagonist (IL-1Ra) (n¼ 3), (B and C) 100 μM SC-514 (SC) (n¼ 3), (D and E) 10 μM SB203580 (SB), 20 μM SP600125 (SP) or 10
μM AZD6244 (AZ) for inhibition of p38 MAPK, JNK or MEK1/2 respectively (n¼ 5 for mRNA and n¼ 3 for protein). **P < 0.01, ***P < 0.001 vs. control; #P < 0.05,
##P < 0.01, ###P < 0.001 vs. IL-1β, ~~~ P < 0.001 vs. IL-1β þ DMSO (one-way repeated measures ANOVA with Tukey's multiple comparison test). Full-length blots
of panels C and E are presented in Supplementary Fig. S1 and S2, respectively.
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of co-culture, calcein could be detected in the underlying CFs, suggesting
the formation of functional heterocellular GJs. Additionally, there were
regions of the CM membrane that were being “pulled” by the CFs, sug-
gesting mechanical interactions between the cells (Figure 5A). While is it
difficult to see the CF monolayer on the bright field images, vimentin
immunofluorescence, following the completion of these experiments,
along with the presence of calcein in the CFs, shows the CF monolayer
(Figure 5B).53.4. CM contraction duration is shortened in the presence of CFs and this
effect is prevented by IL-1β treatment of CFs
CMs in culture alone (control) or in the presence of a CF monolayer
þ/- IL-1β treatment maintained their rod-like morphology and remained
responsive to electrical stimulus (Figure 6A). The CD of CMs cultured
alone (control) or in the presence of untreated or IL-1β-treated CFs was
examined using a proprietary cell motion algorithm on Image J
(Figure 6A). The rise time of the contraction was unaltered between the
Figure 4. Effect of IL-1β or TGFβ1 alone or in combination on the mRNA expression of CTGF and αSMA in CFs. Quiesced cells were stimulated with IL-1β, TGFβ1 or IL-
1β plus TGFβ1 (all at 10 ng/mL) for 24 h. Cells maintained in 0.5% FBS media were used as a control. mRNA levels of (A) CTGF or (B) αSMA was examined. Data
represented as relative quantification (RQ)  rqmax normalised to UBC (n¼3). *P < 0.05, ***P < 0.001 vs. control; #P < 0.05, ###P < 0.001 vs. TGFβ1 (one-way
repeated measures ANOVA with Tukey's multiple comparison test).
Figure 5. Localisation of calcein in CMs and CFs and
vimentin immunofluorescence in co-cultures. (A) Freshly
isolated CMs were loaded with 5 μM calcein for 30 min at
37 C and washed three times in PBS. 1104 rod shaped
CMs in 0.5% FBS media were then added to a CF mono-
layer in 35 mm glass bottomed petri dishes. The local-
isation of calcein was visualised immediately following CM
addition (0–1 h) then again following 20 h (upper and
middle panels respectively). The areas surrounded in the
red box in the middle panel are expanded in the bottom
panel showing calcein dye transfer to the underlying CFs
depicted by white arrows. Red arrows show examples of
areas of the CM being pulled by the underlying CFs. Images
were taken on the Zeiss 510 LSM confocal microscope.
Scale bar represents 100 μm on the upper and middle
panels and 50 μm on the lower panel (n¼3). (B) Cultures
were fixed following 24 h following of co-culture and
stained for vimentin. All images were taken at x25
magnification on the Zeiss 510 LSM confocal microscope
and normalised to an IgG control. Scale bar represents 100
μm (n¼3).
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Figure 6. Contraction measurements from
CMs cultured alone, with an CF monolayer
or with an IL-1β treated CF monolayer. (A)
Representative traces and images of CMs
cultured alone (top), with a CF monolayer
(middle) or with an IL-1β treated CF
monolayer (bottom). Scale bar represents
200 ms. (B) 10–90% rise times and (C)
CD50 values from CMs from three hearts.
Each point represents an individual cell and
the mean is denoted by a line. n¼ 33, n¼ 29
and n¼ 25 for control, CF monolayer and
IL-1β CF monolayer groups respectively
from three animals. *P < 0.05 vs. control
(one-way repeated measures ANOVA with
Tukey's multiple comparison test performed
on the mean values from each heart). CD50;
time from 50% contraction - 50%
relaxation.
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monolayer, 20.4  0.7 ms; Figure 6B), while the CD50 was significantly
reduced in CMs in co-culture with an untreated CFmonolayer (Figure 6C)
(36.1  1.1 ms vs. 47.3  2.4 ms; CF monolayer vs. control; P < 0.05).
This effect on CM CD50 was lessened when CFs had been pre-treated
with IL-1β (39.6  2.6 ms) (Figure 6C)
3.5. CFs do not alter the action potential of CMs
Next, APs were measured in freshly isolated CMs or CMs cultured
overnight to determine the effect of culture on electrical activity
(Figure 7A). There was no change in the 10–90 % rise time (4.2 0.3 ms
vs. 4.3  0.4 ms, fresh vs. cultured CMs; Figure 7C) or APD80 (45.5  1.2
vs. 55.4  4.4 ms, fresh vs. cultured CMs; Figure 7E) between cultured
CMs and freshly isolated CMs. Additionally, AP measurements taken
from cultured CMs alone (control) or in the presence of an untreated or
IL-1β treated CF monolayer (Figure 7B), showed no differences in 10–90
% rise time (control, 4.3  0.4 ms; CF monolayer, 4.5  0.4 ms; IL-1β CF7monolayer, 4.3 0.2ms; Figure 7D) or APD80 (control, 55.4 4.4 ms; CF
monolayer, 71.0 7.8 ms; IL-1β CF monolayer 65.0 5.5 ms; Figure 7F).
4. Discussion
This study set out to examine potential mediators that could be
responsible for the enhanced Cx43 expression in CFs from experimental
MI hearts. IL-1β was found to be a strong inducer of Cx43 expression in
CFs however it was also shown to reduce the MF-like phenotype of the
cells. Despite this, they are likely to represent a population of CFs in the
damaged heart due to high levels of IL-1β in disease [38]. This expression
of Cx43 was shown to be dependent on the IL-1R and downstream NF-κB,
p38 MAPK and MEK1 signalling. Furthermore, the effect of co-culture of
adult CMs with CFs demonstrated that the CM CD was significantly
shortened in comparison to CMs cultured alone. Interesting, when CFs
were stimulated with IL-1β this effect on CD was ablated, providing
additional evidence that the phenotype of CFs can differentially regulate
the function of CMs.
Figure 7. Action potential measurements from fresh CMs or CMs cultured alone, with an CF monolayer or with a IL-1β treated CF monolayer. An overlay of a
representative average action potential (AP) from (A) a freshly isolated CM and a CM cultured for 24 h and (B) a CM cultured alone (control) or CMs cultured with a CF
monolayer and IL-1β CF monolayer for 24 h (C and D) 10–90% rise time and (E and F) the AP duration of 80% repolarisation (APD80) in respective groups. Scale bar
represents 50 ms. Each point represents an individual cell and the mean from each heart is denoted by a line. Values are separated into individual hearts due to the
large number of cells. n ¼ 85, n ¼ 122, n ¼ 90 and n ¼ 99 for fresh CMs, cultured CMs/control, CF monolayer and IL-1β CF monolayer groups respectively from three
animals. No significant changes were detected between the mean values from each heart using a one-way repeated measures ANOVA with Tukey's multiple com-
parison test.
L. McArthur et al. Heliyon 6 (2020) e03031IL-1β induced upregulation of Cx43 levels is in agreement with pre-
vious findings in a rabbit synovial fibroblast cell line (HIG-82 cells) [39].
Additionally, stimulation of bladder smooth muscle cells (SMCs) with
both IL-1β and TNFα increased Cx43 expression through activation of8NF-κB and PKA [40]. NF-κB binding sites have been detected in the Cx43
promoter and have been shown to be important in Cx43 regulation [41].
In the present study, the IL-1β-mediated Cx43 increase in CFs was also
found to be dependent on NF-κB, following activation through the IL1R.
L. McArthur et al. Heliyon 6 (2020) e03031Furthermore, inhibition of MEK1 significantly blunted Cx43 mRNA
upregulation by IL-1β and reduced IL-1β mediated increase in Cx43
protein. Similarly, ERK1/2, which is downstream of MEK1, activation
has been shown to promote Cx43 upregulation in various cell types [42,
43]. Conversely, there was no significant effect on Cx43 mRNA expres-
sion following inhibition of p38 MAPK or JNK, other known IL-1β target
signalling proteins [39]. Protein levels of Cx43 were increased by IL-1β,
in the absence but not presence of p38 MAPK and MEK1 inhibitors.
In the current study, CFs in culture were shown to express αSMA: a
marker of the MF phenotype. The development of αSMA expression is
well established to occur in vitro following passage [44, 45]. However,
although cultured CFs express αSMA and have some similarities, such as
inducing similar reductions on the CM Ca2þ transient [45], they have
been reported to be dissimilar in phenotype from MFs resident in vivo
[45, 46]. In the present study, IL-1βwas found to significantly reduce the
mRNA expression of the MF markers, CTGF and αSMA, as well as
significantly inhibiting TGFβ1-mediated increase in CTGF. Similar find-
ings have been reported elsewhere [27, 47].
As well as altering the phenotype of CFs, IL-1β and TGFβ1 are known
to have a diverse range of actions followingMI. IL-1β is a key driver of the
inflammatory phase of cardiac repair, attracting inflammatory cells to the
infarct and promoting the release of other proinflammatory mediators
[33, 48]. The inflammatory role of TGFβ appears to be more complex
with reports of pro- and anti-inflammatory actions, however it is well
established to drive healing of the infarct, partly via activation of MFs
[49]. Although both IL-1β and TGFβ mRNA have been reported to be
enhanced as early as 15 min following MI [50], results from the current
study and that of others [27] may suggest that IL-1β acts to suppress
TGFβ1-mediated activation of CFs, allowing the infarct to cleared of
debris prior to scar formation.
The adult co-culture model utilised in this study allows many in-
teractions between the cells to occur, including those of a paracrine,
mechanical and electrical nature, due to media sharing and direct contact
allowing the formation of mechanical and GJs. Therefore, it is chal-
lenging to interpret what is responsible for the results observed, hence
further studies are required to dissect potential mechanisms. Evidence for
the formation of both mechanical and GJs was provided in the current
study where areas of the CMs were visualised to be “pulled” by under-
lying CFs and calcein was transferred from CMs to CFs following 20 h of
co-culture, respectively.
As control untreated CFs maintained an MF-like phenotype in
contrast to IL-1β treated CFs, based on CTGF and SMA detection, this may
provide an explanation to the greater effect on CM function following co-
culture of CMs with control CFs (MF-like) in comparison to CMs co-
cultured with IL-1β-treated CFs (less MF-like). Additionally, mechanical
interactions between adult CMs and CFs were observed in our model,
which has also been reported by others [10, 51]. As αSMA is part of the
cytoskeleton that determines the mechanical properties of cells [27, 52],
the levels of αSMA in CFs is likely to influence the mechanical effects on
coupled CMswhen in co-culture. This may be a contributing factor for the
reduction in CD of CMs in co-culture with control CFs, that have greater
expression of αSMA, due to an enhanced contractile force and restriction
of normal CM contraction. The reduced αSMA in CFs following IL-1β
treatment could contribute to less contractile force, consequently
elevating contraction restriction of mechanically coupled CMs and effects
on CD. Indeed, IL-1β was shown to inhibit TGFβ-mediated contraction of
collagen pads by CFs [27], supporting this hypothesis. Furthermore, as
CM contraction is reliant on Ca2þ, changes in contraction likely reflect
alterations in Ca2þ handling. It is known that the degree of muscle/-
sarcomere shortening can influence the time course of the Ca2þ transient
in cardiac muscle [53], resulting from the effect of sarcomere length on
Ca2þ binding to myofilaments [54]. Thus, the mechanical status of the
CMs in co-culture could influence the time course of intracellular Ca2þ
and therefore CD. However, it must be noted that only mRNA levels of
αSMA were examined in the current study and others have reported no9change in the protein level following 48 h stimulation with IL-1β, despite
reduced levels of mRNA [18]. Therefore, αSMA protein requires evalu-
ation to support this hypothesis. Despite this, a role of αSMA in CF
modulating CM function has been previously established, where treating
CFs with actin targeting drugs reduced the slowing of CV, ectopic activity
and the depolarising effect of CFs in a neonatal CM:CF co-culture model
[20].
Although, IL-1β treated CFs had increased expression of Cx43, the CD
of CMs was less affected in this condition in comparison to culture with
control CFs. This would therefore suggest that the difference in CD was
not attributed to Cx43 expression in CFs. However, the degree of
coupling and functionality of potential GJs formed was not examined in
cultures that had IL-1β-treated CFs.
As well as direct cell-to-cell interactions, the model used in the cur-
rent study allows for paracrine heterocellular interactions to occur which
may also have effects on CM contraction. Indeed, spontaneous contrac-
tions of neonatal CMs were inhibited following treatment with fibroblast
conditioned media for 72 h, in comparison to control CM cultures which
displayed continued contractions [55]. Furthermore, although Ca2þ was
not measured in the current study, previous work found the Ca2þ tran-
sient decay to be faster in adult CMs in a CM: CF co-culture transwell
model in comparison to CMs alone [45]. This could explain the results of
the present study due to quicker uptake/efflux of Ca2þ in the presence of
CFs, therefore leading to reduced CD. Interestingly, in this previous
study, this effect on the Ca2þ transient was ablated by TGFβ inhibition,
demonstrating a role for TGFβ signalling between the cell types [45].
In the current study, culturing CMs alone or with a CF monolayer
(control or IL-1β-treated) had no effect on CM AP rise time or APD80.
Similarly, culturing swine adult CMs for 24 h showed no significant
change in APD90, however there was a progressive prolongation over 72
h [56]. Typically, paracrine factors released from CFs have been reported
to induce a prolongation in the APD of CMs [6, 15, 57]. Additionally,
Cx43 expression in CFs was shown to contribute to the prolonged APD
duration observed in neonatal CM: CF co-cultures [13]. In the present
study, even after enhanced Cx43 expression, in IL-1β treated CFs, there
was no significant alteration in the electrical characteristics of
co-cultured CMs in comparison to control CMs. This suggests that any
electrical load on CMs as a result of coupling to CFs was not sufficient to
change electrical parameters. This is in agreement to a similar co-culture
model to the one utilised in the current study with adult rabbit CMs,
where there was no difference in APD90, despite sharing of media and
evidence for coupling between the cells [9]. The difference to studies
involving neonatal CMs is that they have different overall electrical
properties [58, 59], therefore may be more easily influenced by coupling
to CFs. However, a limitation to this co-culture model is that it is unlikely
that all CMs studied were coupled to CFs, therefore differences in well
coupled CMs could be diluted and no significant changes detected. Also, a
further limitation is that we did not include any positive controls that
effect electrical activity in this model.
In summary, our results have shown that IL-1β enhances the
expression of Cx43 in CFs through the classical IL-1 signalling pathway.
Furthermore, control CFs were demonstrated to alter the function of
adult rat CMs by reducing the CD in CMs; an effect that was not
apparent when CFs were pre-treated with IL-1β. This demonstrates that
the phenotype of CFs is important in heterocellular interactions and
further studies are required to dissect the mechanisms responsible for
this effect.
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